e-learning
resources
Virtual 2020
Tuesday, 08.09.2020
Airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
ERS Short Guideline: Inhaled corticosteroid withdrawal in COPD
M. Miravitlles (Barcelona (CT), Spain)
Source:
Virtual Congress 2020 – Airway diseases
Session:
Airway diseases
Session type:
State of the art session
Number:
4515
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Miravitlles (Barcelona (CT), Spain). ERS Short Guideline: Inhaled corticosteroid withdrawal in COPD. Virtual Congress 2020 – Airway diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline
Source: Guideline 2020
Year: 2020
Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline
Source: Eur Respir J, 55 (6) 2000351; 10.1183/13993003.00351-2020
Year: 2020
Microbiome Use to Stratify Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (MUSIC) trial: baseline data and impact of inhaled corticosteroid withdrawal in severe COPD with frequent exacerbations
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020
The effect of Corticophobia on Inhaled Corticosteroid Treatment Compliance In Adults with Asthma
Source: International Congress 2018 – Asthma analysis
Year: 2018
Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety
Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Year: 2013
ERS guideline on withdrawal of inhaled corticosteroids in COPD
Source: ERS webinar 2021: ERS guideline on withdrawal of inhaled corticosteroids in COPD
Year: 2021
Long-acting beta2 agonist without concomitant inhaled corticosteroids in children with asthma in primary care
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Adherence with inhaled corticosteroids in asthma: Does pregnancy lead to improved adherence?
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
Late Breaking Abstract - Impact of maintenance and reliever therapy (MART)-focused asthma guideline on SABA prescriptions
Source: Virtual Congress 2021 – Highlights for primary care in 2021
Year: 2021
Inhaled corticosteroids in COPD: the case against
Source: Eur Respir J 2009; 34: 13-16
Year: 2009
The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014
Efficacy and safety of indacaterol acetate on ICS background therapy in asthma
Source: International Congress 2014 – Asthma and COPD management
Year: 2014
Inhaled corticosteroids: a controversial add-on treatment in COPD
Source: Eur Respir J 2010; 36: 973-974
Year: 2010
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
Tiotropium as add-on to inhaled corticosteroids significantly improves asthma control as reflected by the ACQ responder rate
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
Bronchodilator responsiveness after ICS treatment
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016
Evaluation of Asthma control and oral corticosteroids in Severe Asthma
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Late Breaking Abstract - Management of asthma in pregnancy using fractional exhaled nitric oxide (FENO) to adjust inhaled corticosteroid (ICS) dose did not improve perinatal outcomes: the Breathing for Life Trial (BLT)
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020
Effect of inhaled steroid therapy on treatment response in hosptalized pneumonia patients: Results from Turkish Thoracic Society database
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept